An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures
Clinical trial NCT04686786 · TERMINATED
Trial details
- NCT number
- NCT04686786
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2024-12-05
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.